NAS:BVXV (Israel)  
BiondVax Pharmaceuticals Ltd logo

BiondVax Pharmaceuticals Ltd

$ 7.74 -1.567 (-16.84%) 10:08 PM EST
P/E:
N/A
P/B:
28.82
Market Cap:
$ 14.63M
Enterprise V:
$ 25.57M
Volume:
31.29K
Avg Vol (2M):
7.27K
Also Trade In:
Volume:
31.29K
Market Cap $:
14.63M
PE Ratio:
N/A
Avg Vol (2-Month):
7.27K
Enterprise Value $:
25.57M
PB Ratio:
28.82
GF Score:
Year:
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
BiondVax Pharmaceuticals Ltd is a biopharmaceutical company focused on developing, manufacturing and commercializing innovative products for the prevention and treatment of infectious diseases and other illnesses. It has executed eight clinical trials in seven countries, around 12,400 participants in the Phase 3 trial of its vaccine candidate and has built a state-of-the-art manufacturing facility for biopharmaceutical products. The company is aiming to develop a pipeline of diversified and commercially viable products and platforms beginning with an innovative nanosized antibody (NanoAb) pipeline.
Name Current Vs Industry Vs History
Cash-To-Debt 0.51
Equity-to-Asset 0.05
Debt-to-Equity 17.25
Debt-to-EBITDA -2.7
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year EBITDA Growth Rate 28.8
3-Year FCF Growth Rate 32.6
Name Current Vs Industry Vs History
5-Day RSI 23.78
9-Day RSI 35.34
14-Day RSI 41.6
6-1 Month Momentum % -44.44
12-1 Month Momentum % -61.95

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 1.71
Quick Ratio 1.71
Cash Ratio 1.68

Dividend & Buy Back

Name Current Vs Industry Vs History
Name Current Vs Industry Vs History
ROE % -353.25
ROA % -46.76
ROIC % -50.3
ROC (Joel Greenblatt) % -68.44
ROCE % -56.4

GF Value Rank

Name Current Vs Industry Vs History
PE Ratio N/A
N/A
N/A
PE Ratio without NRI N/A
N/A
N/A
PB Ratio 28.82
Price-to-Tangible-Book 24.19
EV-to-EBIT -5.45
EV-to-EBITDA -5.82
EV-to-FCF -7.09
Earnings Yield (Greenblatt) % -18.35

Financials (Next Earnings Date:2023-01-28 Est.)

BVXV's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:BVXV

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -9.336
Beta 2.6
Volatility % 81.76
14-Day RSI 41.6
14-Day ATR ($) 0.803729
20-Day SMA ($) 8.70945
12-1 Month Momentum % -61.95
52-Week Range ($) 5.335 - 34.9
Shares Outstanding (Mil) 1.89

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

BiondVax Pharmaceuticals Ltd Filings

Document Form Filing Date
No Filing Data

BiondVax Pharmaceuticals Ltd Analysis

Share your research

Headlines

See More
No news.